Target intelligence / Profile preview

ELOA antisense RNA 1 (ELOA-AS1)

Target
ELOA-AS1
Molecular classification
Non-coding RNA (ncRNA), Antisense RNA, Long non-coding RNA (lncRNA)
01

Overview

ELOA antisense RNA 1 (ELOA-AS1) is a human gene that encodes a long non-coding RNA transcribed from the ELOA locus on chromosome 1. It is classified as an antisense RNA, meaning it is transcribed from the strand opposite to the ELOA (elongin A) gene. Antisense RNAs like ELOA-AS1 can potentially regulate the expression of adjacent or overlapping protein-coding genes through various mechanisms but there is currently no direct evidence for a defined biological function, disease role, or drug targeting of ELOA-AS1[1][4][6]. ELOA-AS1 is not considered a canonical drug target, and no drugs or biomarkers are currently associated with it[4][6]. Expression data indicate presence in tissues such as the adrenal gland and cortex, but biological significance is unclear[5]. If structured database information for this lncRNA becomes available in the future, associations with gene regulation, disease roles, or biomarker utility could be added. For now, it remains a well-defined gene entity without established therapeutic relevance.

Other names
TCEB3-AS1TCEB3 antisense RNA 1ELOA-AS1
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on ELOA antisense RNA 1 (ELOA-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ELOA antisense RNA 1 (ELOA-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call